Remodulin

NDC 66302-101 · United Therapeutics Corporation

Generic nametreprostinil

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)TREPROSTINIL

Strength20 mg/20mL

Pharmacologic classProstacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]

Marketing categoryNDA

Packages

66302-101-01 — 1 VIAL in 1 BOX (66302-101-01) / 20 mL in 1 VIAL

J3285 — Injection, treprostinil, 1 mg Medicare Part B payment limit (ASP + 6%): $54.74

FDA lists these products with the same active ingredient.

0781-3427 — treprostinil, 0781-3430 — treprostinil, 43598-646 — Treprostinil, 43598-647 — Treprostinil, 43598-648 — Treprostinil, 43598-649 — Treprostinil, 62332-514 — Treprostinil, 62332-515 — Treprostinil, 62332-516 — Treprostinil, 62332-517 — Treprostinil, 66302-102 — treprostinil, 66302-105 — treprostinil, 66302-110 — treprostinil, 66302-114 — treprostinil, 66302-206 — treprostinil, 66302-300 — treprostinil, 66302-302 — treprostinil, 66302-310 — treprostinil, 66302-325 — treprostinil, 66302-350 — treprostinil, +16 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.